Clay Siegall. (Seagen Photo) Clay Siegall is proud of his legacy as co-founder and longtime CEO of Seagen, the largest biotech company in the Seattle area. “I built a great company,” Siegall said in an exclusive interview with GeekWire on ...

Clay Siegall. (Seagen Photo) Seagen founder Clay Siegall is jumping back into the biotech world as CEO and president of Morphimmune. Founded in 2020, the Purdue University spinout will relocate its headquarters to the Seattle area, with Siegall at the ...

Rendering of Seagen’s new planned manufacturing facility north of Seattle. (Seagen Image) Seattle-area biotech experts are eying the past with a wary eye in the wake of this week’s news that Pfizer plans to acquire Bothell, Wash.-based Seagen for a ...

Neoleukin CEO Jonathan Drachman. (Neoleukin Photo) Neoleukin Therapeutics is slashing its workforce by about 70% as it seeks “strategic alternatives” for its future, according to a company statement Wednesday. The publicly traded Seattle biotech company hired investment bank SVB Securities ...